...
首页> 外文期刊>Immunobiology: Zeitschrift fur Immunitatsforschung >Chemokines and other GPCR ligands synergize in receptor-mediated migration of monocyte-derived immature and mature dendritic cells
【24h】

Chemokines and other GPCR ligands synergize in receptor-mediated migration of monocyte-derived immature and mature dendritic cells

机译:趋化因子和其他GPCR配体协同作用于受体介导的单核细胞来源的未成熟和成熟树突状细胞的迁移

获取原文
获取原文并翻译 | 示例
           

摘要

Dendritic cells (DCs) are potent antigen presenting cells, described as the initiators of adaptive immune responses. Immature monocyte-derived DCs (MDDC) showed decreased CD14 expression, increased cell surface markers DC-SIGN and CD1a and enhanced levels of receptors for the chemokines CCL3 (CCR1/CCR5) and CXCL8 (CXCR1/CXCR2) compared with human CD14+ monocytes. After further MDDC maturation by LPS, the markers CD80 and CD83 and the chemokine receptors CXCR4 and CCR7 were upregulated, whereas CCR1, CCR2 and CCR5 expression was reduced. CCL3 dose-dependently synergized with CXCL8 or CXCL12 in chemotaxis of immature MDDC. CXCL12 augmented the CCL3-induced ERK1/2 and Akt phosphorylation in immature MDDC, although the synergy between CCL3 and CXCL12 in chemotaxis of immature MDDC was dependent on the Akt signaling pathway but not on ERK1/2 phosphorylation. CCL2 also synergized with CXCL12 in immature MDDC migration. Moreover, two CXC chemokines not sharing receptors (CXCL12 and CXCL8) cooperated in immature MDDC chemotaxis, whereas two CC chemokines (CCL3 and CCL7) sharing CCR1 did not. Further, the non-chemokine G protein-coupled receptor ligands chemerin and fMLP synergized with respectively CCL7 and CCL3 in immature MDDC signaling and migration. Finally, CXCL12 and CCL3 did not cooperate, but CXCL12 synergized with CCL21 in mature MDDC chemotaxis. Thus, chemokine synergy in immature and mature MDDC migration is dose-dependently regulated by chemokines via alterations in their chemokine receptor expression pattern according to their role in immune responses.
机译:树突状细胞(DC)是有效的抗原呈递细胞,被描述为适应性免疫应答的启动子。与人CD14 +单核细胞相比,未成熟单核细胞衍生的DC(MDDC)显示出CD14表达降低,细胞表面标志物DC-SIGN和CD1a增加以及趋化因子CCL3(CCR1 / CCR5)和CXCL8(CXCR1 / CXCR2)受体水平提高。 LPS使MDDC进一步成熟后,标志物CD80和CD83以及趋化因子受体CXCR4和CCR7被上调,而CCR1,CCR2和CCR5的表达则降低。 CCL3在未成熟MDDC的趋化性中与CXCL8或CXCL12剂量依赖性协同作用。 CXCL12增强了未成熟MDDC中CCL3诱导的ERK1 / 2和Akt磷酸化,尽管在未成熟MDDC趋化性中CCL3和CXCL12之间的协同作用取决于Akt信号通路,而不取决于ERK1 / 2磷酸化。在不成熟的MDDC迁移中,CCL2也与CXCL12协同作用。此外,两个不共享受体的CXC趋化因子(CXCL12和CXCL8)在未成熟的MDDC趋化性中协同作用,而两个共享CCR1的CC趋化因子(CCL3和CCL7)则不参与。此外,非趋化因子G蛋白偶联受体配体chemerin和fMLP在未成熟的MDDC信号传导和迁移中分别与CCL7和CCL3协同作用。最后,CXCL12和CCL3不合作,但CXCL12在成熟的MDDC趋化性中与CCL21协同作用。因此,不成熟和成熟MDDC迁移中的趋化因子协同作用通过其趋化因子受体表达模式的改变,根据其在免疫应答中的作用,由趋化因子剂量依赖性地调节。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号